Institutional investors tell Big Pharma to cooperate on coronavirus [Reuters (UK)]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Reuters
Institutional investors tell Big Pharma to cooperate on coronavirus - Reuters 3 Min Read AMSTERDAM (Reuters) - Institutional investors in 15 major pharmaceutical companies have called on the drugmakers to set aside rivalries and short-term interests and cooperate on finding solutions to the coronavirus. The investor group - which holds more than 1.9 trillion euros ($2.1 trillion) in assets and includes Nordea, Nomura, Boston Common Asset Management and Dutch pension fund PGGM - said it will send drugmakers including Roche ( ROG.S ), Johnson & Johnson ( JNJ.N ) and Gilead ( GILD.O ), a list of principles it wants them to abide by for the coming year. The list includes prioritising the development of tests, medicines and vaccines, working together on data-sharing, paying suppliers on time, understanding if customers have financial hardship and ensuring supply lines are working. The group said in a statement dated April 16 that it had “unfortunately... seen some examples of priorit
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- GDV's 6.1% Yield Faces a Hidden Test in 2026 Small-Cap Downturn [Yahoo! Finance]Yahoo! Finance
- 3 Giant Dividend Stocks Raising Payouts With Yields Up to 4% [Yahoo! Finance]Yahoo! Finance
- Global Laparoscopy Devices Market to Register Immense Growth at a CAGR of ~9% by 2034 | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Fidelity Contrafund Q1 2026 Commentary [Seeking Alpha]Seeking Alpha
- Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut of CARTOSOUND SONATA, to Advance Arrhythmia Care at HRS 2026 [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/14/26 - Beat
JNJ
Sec Filings
- 4/14/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- 3/18/26 - Form 13F-HR/A
- JNJ's page on the SEC website